Director Gary Cantrell to retire from Aytu BioPharma board effective Dec. 31, 2022

AYTU BIOPHARMA, INC

Gary Cantrell notified Aytu BioPharma of his intention to retire from the Board, effective December 31, 2022.
Mr. Cantrell did not advise the Company of any disagreement with its operations, policies, or practices.
Aytu is initiating a search for an additional member of the Board of Directors.
The retirement is a planned departure, not due to any dispute or controversy.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Gary Cantrell

Member of the Board of Directors

AYTU · AYTU BIOPHARMA, INC

Effective: 2022-12-31
Filed: December 27, 2022, 6:59 PM ET

On December 22, 2022, Gary Cantrell, a member of the Board of Directors of Aytu BioPharma, Inc. (the “Company”), notified the Company of his intention to retire from the Company's Board of Directors, effective December 31, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Gary Cantrell departed as Member of the Board of Directors at AYTU BIOPHARMA, INC.

Action: retire
Role: Member of the Board of Directors

Exact text from the filing

On December 22, 2022, Gary Cantrell, a member of the Board of Directors of Aytu BioPharma, Inc. (the “Company”), notified the Company of his intention to retire from the Company's Board of Directors, effective December 31, 2022.

View on SEC.gov

AYTU BIOPHARMA, INC filing history →

Source: SEC EDGAR

accession 0001558370-22-018991

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.